SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479290-20-000105
Filing Date
2020-11-09
Accepted
2020-11-09 16:46:12
Documents
85
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvnc-20200930.htm   iXBRL 10-Q 2146738
2 EX-10.1 rvncq320ex101areeagree.htm EX-10.1 41559
3 EX-10.2 rvncq32010-qexhibit102.htm EX-10.2 186829
4 EX-10.5 rvncq32010-qexhibit105.htm EX-10.5 25248
5 EX-31.1 rvncq32010-qexhibit311.htm EX-31.1 8786
6 EX-31.2 rvncq32010-qexhibit312.htm EX-31.2 8785
7 EX-32.1 rvncq32010-qexhibit321.htm EX-32.1 6513
8 EX-32.2 rvncq32010-qexhibit322.htm EX-32.2 6541
  Complete submission text file 0001479290-20-000105.txt   8751295

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20200930.xsd EX-101.SCH 51126
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20200930_cal.xml EX-101.CAL 109574
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20200930_def.xml EX-101.DEF 306350
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20200930_lab.xml EX-101.LAB 646492
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20200930_pre.xml EX-101.PRE 444918
14 EXTRACTED XBRL INSTANCE DOCUMENT rvnc-20200930_htm.xml XML 1358026
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 201298355
SIC: 2834 Pharmaceutical Preparations